Sarcopenia in interstitial lung disease
Background Interstitial lung disease (ILD) encompasses a heterogeneous group of chronic lung conditions with considerable variability in prognosis and response to treatment. People with reduced muscle mass and function, known as sarcopenia, have a higher risk of mortality and adverse clinical outcom...
Saved in:
Main Authors: | Robert Sheehy, Samuel McCormack, Caitlin Fermoyle, Tamera Corte |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2024-12-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/33/174/240126.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interstitial Lung Disease, the Basics
by: Adriana Dubbeldam
Published: (2024-11-01) -
Interstitial lung disease in rheumatic diseases
by: Sham Santhanam, et al.
Published: (2021-01-01) -
Smoking‑Related Interstitial Lung Disease
by: Bart Ilsen
Published: (2024-11-01) -
Spectrum of interstitial lung disease in rheumatic diseases
by: Gouri Koduri, et al.
Published: (2021-01-01) -
Lung transplantation in connective tissue disease associated interstitial lung disease
by: Srinivas Rajagopala, et al.
Published: (2021-01-01)